Ultragenyx Pharmaceutical Inc.

VICTORY CAPITAL MANAGEMENT INC RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

19,907

Value ($000)

458

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	458	0.0%	19,907	12/31/2025
2025 Q3	11/12/2025	8,991	0.0%	298,891	9/30/2025
2025 Q2	8/13/2025	15,116	0.0%	415,733	6/30/2025
2025 Q1	5/2/2025	378	0.0%	10,430	3/31/2025
2024 Q4	2/6/2025	434	0.0%	10,306	12/31/2024
2024 Q3	11/5/2024	608	0.0%	10,948	9/30/2024
2024 Q2	8/5/2024	414	0.0%	10,064	6/30/2024
2024 Q1	5/3/2024	474	0.0%	10,159	3/31/2024
2023 Q4	2/5/2024	505	0.0%	10,565	12/31/2023
2023 Q3	11/6/2023	260	0.0%	7,306	9/30/2023
2023 Q2	7/27/2023	330	0.0%	7,150	6/30/2023
2023 Q1	5/2/2023	293	0.0%	7,317	3/31/2023
2022 Q4	4/25/2023	342	0.0%	7,392	12/31/2022
2022 Q3	11/2/2022	306	0.0%	7,395	9/30/2022
2022 Q2	8/1/2022	446	0.0%	7,468	6/30/2022
2022 Q1	5/4/2022	527	0.0%	7,459	3/31/2022
2021 Q4	2/7/2022	625	0.0%	7,438	12/31/2021
2021 Q3	11/2/2021	597	0.0%	6,615	9/30/2021
2021 Q2	8/3/2021	588	0.0%	6,167	6/30/2021
2021 Q1	5/4/2021	731	0.0%	6,417	3/31/2021
2020 Q4	2/1/2021	936	0.0%	6,760	12/31/2020
2020 Q3	11/9/2020	388	0.0%	4,720	9/30/2020
2020 Q2	8/7/2020	393	0.0%	5,024	6/30/2020
2020 Q1	5/4/2020	236	0.0%	5,315	3/31/2020
2019 Q4	2/6/2020	316	0.0%	7,400	12/31/2019